萘普生用于青少年慢性多关节炎。
Naproxen in juvenile chronic polyarthritis.
作者信息
Moran H, Hanna D B, Ansell B M, Hall M, Engler C
出版信息
Ann Rheum Dis. 1979 Apr;38(2):152-4. doi: 10.1136/ard.38.2.152.
Abstract
Naproxen at 10 mg per kg body weight was compared with aspirin at 80 mg per kg body weight in children suffering from juvenile chronic polyarthritis. It was found to be as effective as aspirin, with certainly no more and possibly fewer gastrointestinal side effects. A long-term tolerance study up to 12 months confirmed that naproxed was a satisfactory nonsteroidal anti-inflammatory drug in the management of various types of juvenile chronic arthritis.
摘要
在患有青少年慢性多关节炎的儿童中，对每千克体重服用10毫克萘普生与每千克体重服用80毫克阿司匹林进行了比较。结果发现它与阿司匹林效果相同，胃肠道副作用肯定不会更多，甚至可能更少。一项长达12个月的长期耐受性研究证实，萘普生在治疗各种类型的青少年慢性关节炎方面是一种令人满意的非甾体抗炎药。
相似文献
1
Naproxen in juvenile chronic polyarthritis.萘普生用于青少年慢性多关节炎。
Ann Rheum Dis. 1979 Apr;38(2):152-4. doi: 10.1136/ard.38.2.152.
2
Non-steroidal anti-inflammatory drugs (NSAIDs) for chronic non-cancer pain in children and adolescents.用于儿童和青少年慢性非癌性疼痛的非甾体抗炎药（NSAIDs）
Cochrane Database Syst Rev. 2017 Aug 2;8(8):CD012537. doi: 10.1002/14651858.CD012537.pub2.
3
Naproxen and acetylsalicylic acid in the treatment of pauciarticular and polyarticular juvenile rheumatoid arthritis. Assessment of tolerance and efficacy in a single-centre 24-week double-blind parallel study.
Scand J Rheumatol. 1984;13(4):342-50. doi: 10.3109/03009748409111307.
4
Naproxen in the treatment of juvenile rheumatoid arthritis. Metabolism, safety and efficacy.萘普生治疗青少年类风湿性关节炎：代谢、安全性与疗效
Scand J Rheumatol. 1977;6(4):193-205. doi: 10.3109/03009747709095449.
5
Gastrointestinal microbleeding after aspirin and naproxen.阿司匹林和萘普生后的胃肠道微出血。
Clin Pharmacol Ther. 1978 Apr;23(4):402-7. doi: 10.1002/cpt1978234402.
6
Gastrointestinal safety of celecoxib versus naproxen in patients with cardiothrombotic diseases and arthritis after upper gastrointestinal bleeding (CONCERN): an industry-independent, double-blind, double-dummy, randomised trial.在上消化道出血后患有心血管血栓疾病和关节炎的患者中，塞来昔布与萘普生的胃肠道安全性 (CONCERN)：一项产业独立、双盲、双模拟、随机试验。
Lancet. 2017 Jun 17;389(10087):2375-2382. doi: 10.1016/S0140-6736(17)30981-9. Epub 2017 Apr 11.
7
A crossover study of naproxen, diclofenac and tolmetin in seronegative juvenile chronic arthritis.
Clin Exp Rheumatol. 1988 Apr-Jun;6(2):157-60.
8
[Diflunisal compared with naproxen in chronic polyarthritis. Double-blind study].[双氯芬酸与萘普生治疗慢性多关节炎的比较。双盲研究]
Schweiz Med Wochenschr. 1982 Feb 20;112(8):281-5.
9
Two double blind trials of diclofenac sodium with aspirin and with naproxen in the treatment of patients with rheumatoid arthritis.
J Rheumatol. 1988 Aug;15(8):1205-11.
10
Comparative effects of naproxen and aspirin on fever in children.萘普生和阿司匹林对儿童发热的比较效果。
J Pediatr. 1979 Oct;95(4):626-9. doi: 10.1016/s0022-3476(79)80784-2.
引用本文的文献
1
Efficacy and Safety of NSAIDs in Infants: A Comprehensive Review of the Literature of the Past 20 Years.非甾体抗炎药（NSAIDs）在婴儿中的疗效和安全性：对过去 20 年文献的综合回顾。
Paediatr Drugs. 2022 Nov;24(6):603-655. doi: 10.1007/s40272-022-00514-1. Epub 2022 Sep 2.
2
Non-steroidal anti-inflammatory drugs (NSAIDs) for chronic non-cancer pain in children and adolescents.用于儿童和青少年慢性非癌性疼痛的非甾体抗炎药（NSAIDs）
Cochrane Database Syst Rev. 2017 Aug 2;8(8):CD012537. doi: 10.1002/14651858.CD012537.pub2.
3
Assessment and management of pain in juvenile idiopathic arthritis.评估和管理青少年特发性关节炎的疼痛。
Paediatr Drugs. 2014 Dec;16(6):473-81. doi: 10.1007/s40272-014-0094-0.
4
2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features.2011 年美国风湿病学会治疗幼年特发性关节炎的建议：关节炎和全身表现治疗药物的起始治疗和安全性监测。
Arthritis Care Res (Hoboken). 2011 Apr;63(4):465-82. doi: 10.1002/acr.20460.
5
Sumatriptan-naproxen fixed combination for acute treatment of migraine: a critical appraisal.舒马曲坦-萘普生固定复方制剂用于偏头痛急性治疗的批判性评价
Drug Des Devel Ther. 2010 Feb 18;4:9-17. doi: 10.2147/dddt.s8410.
6
Medical management of children with juvenile rheumatoid arthritis.青少年类风湿关节炎患儿的医学管理
Drugs. 1999 Nov;58(5):831-50. doi: 10.2165/00003495-199958050-00006.
7
Clinical pharmacokinetics of drugs used in juvenile arthritis.青少年关节炎用药的临床药代动力学
Clin Pharmacokinet. 1991 Aug;21(2):129-49. doi: 10.2165/00003088-199121020-00004.
8
Naproxen up to date: a review of its pharmacological properties and therapeutic efficacy and use in rheumatic diseases and pain states.萘普生最新进展：对其药理特性、治疗效果以及在风湿性疾病和疼痛状态中的应用的综述。
Drugs. 1979 Oct;18(4):241-77. doi: 10.2165/00003495-197918040-00001.
本文引用的文献
1
Prognosis in Still's disease.斯蒂尔病的预后。
Bull Rheum Dis. 1959 May;9(9):189-92.
2
Ibuprofen in the management of Still's disease.布洛芬在斯蒂尔病治疗中的应用
Practitioner. 1973 Nov;211(265):659-63.
3
Naproxen. A new non-hormonal anti-inflammatory agent. Studies in rheumatoid arthritis.萘普生。一种新型非激素类抗炎药。类风湿关节炎研究。
Ann Rheum Dis. 1974 Jan;33(1):12-9. doi: 10.1136/ard.33.1.12.
4
Naproxen absorption in children.
Curr Med Res Opin. 1975;3(1):46-50. doi: 10.1185/03007997509113646.
Zotero 插件